Gemini Therapeutics
Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.
http://www.geminitherapeutics.com
Cambridge, MA
Client Opportunity
Gemini Therapeutics is a biotechnology company pioneering precision therapeutics for patients with high-risk genetic profiles linked to dry age-related macular degeneration (AMD) and rare systemic diseases.
They partnered with The Bowdoin Group to help with their Vice President, Clinical Operations hire. This client’s goal was to engage with a candidate with experience with clinical trial study design, recruitment of patients for clinical trials, and cross-functional leadership skills.
- Demonstrates at least 15 years of clinical operations experience managing trials across a range of disease areas
- Deep understanding of clinical trial study design
- Proven track record recruiting patients for global/multi-site clinical trials across Phase 1 to Phase 3
- A big picture and strategic thinker, able to formulate a vision of the future state of the company
The perfect candidate:
- Demonstrates at least 15 years of clinical operations experience managing trials across a range of disease areas
- Deep understanding of clinical trial study design
- Proven track record recruiting patients for global/multi-site clinical trials across Phase 1 to Phase 3
- A big picture and strategic thinker, able to formulate a vision of the future state of the company
TBG Process
- Built out lists of cardiology focused companies
- Leverage The Bowdoin Group’s network within the life sciences
- Network with leaders in the space
-
Services:
- Executive Search
-
Placements:
- VP of Clinical Operations
-
Employee Count:
- 10-49
-
Funding Rounds:
- Post-IPO Equity
- Publicly Traded